We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$98.9M
(-40%)
Cap. Flow
-$63.4M
Cap. Flow
% of AUM
-42.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
–
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SONX
Sonendo, Inc.
SONX
|
+$8.75M |
| 2 |
Danaher
DHR
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Twist Bioscience
TWST
|
+$28.4M |
| 2 |
Bio-Techne
TECH
|
+$13.2M |
| 3 |
Cytek Biosciences
CTKB
|
+$10.8M |
| 4 |
Natera
NTRA
|
+$9.19M |
| 5 |
Guardant Health
GH
|
+$5.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Blue Water Life Science Advisors held 11 positions worth $149M, down 40% from $248M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blue Water Life Science Advisors withdrew a net $63.4M in Q4 2022, closing 3 positions and reducing 5 holdings. Its most notable exit was Twist Bioscience, an estimated $28.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Blue Water Life Science Advisors opened a new position in Sonendo, Inc. worth $13.1M.
- Blue Water Life Science Advisors's largest Q4 2022 buy was Sonendo, Inc.: 4,643,461 shares worth $13.1M.
- Blue Water Life Science Advisors's biggest Q4 2022 reduction was Cytek Biosciences, cutting an estimated $10.8M.
- Blue Water Life Science Advisors fully exited Twist Bioscience in Q4 2022, selling an estimated $28.4M.
- Blue Water Life Science Advisors's ten largest holdings make up 100% of its $149M portfolio in Q4 2022.
- Blue Water Life Science Advisors opened 2 new positions and closed 3 in Q4 2022.
- Blue Water Life Science Advisors's portfolio value fell 40% quarter-over-quarter to $149M.
Based on Blue Water Life Science Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.